HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17. (Q48360515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

Human T-lymphotropic virus 1

25 March 2020

main subject

0 references

author

Yu Sawada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Kaoru Hamada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Ryosuke Hino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Motonobu Nakamura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

24 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

Australasian Journal of Dermatology

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

e154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan

25 March 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FAJD.12701

Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FAJD.12701

Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FAJD.12701

21 January 2018

Identifiers

DOI

10.1111/AJD.12701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736838%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference